PHIO Phio Pharmaceuticals Corp. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$0.99
· of 52w range
· above low
· to high
$0.8452w low
$4.1952w high
Market Cap (MRQ)
$11M
P/E
-0.2
EPS
$-9.08
your badges
52W Range
$1–$4
Analyst Rating
BUY
Price Target
$14
P/E
-0.2
ROE
-57.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
PHIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.99
Market Cap (MRQ)
$11M
P/E
-0.2
EPS
$-9.08
ROE
-57.5%
52W Range
$1–$4
PHIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| July 5, 2024 | 1-for-9 | Reverse |
| Jan. 26, 2023 | 1-for-12 | Reverse |
| Jan. 15, 2020 | 1-for-55 | Reverse |
| Jan. 8, 2018 | 1-for-10 | Reverse |
| April 18, 2016 | 1-for-10 | Reverse |
| July 24, 2013 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2016-12-31 → 2020-12-31
EPS$-9.082021-12-31 → 2024-12-31
Free Cash Flow$-8M2016-12-31 → 2025-12-31
Net margin·2016-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PHIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.25Y avg ≈-2.6 | ≈-2.6 | · | · | |
| P/B (MRQ) | 0.95Y avg ≈2.2 | ≈2.2 | 1.4 | Undervalued | |
| Price / FCF (TTM) | -0.95Y avg ≈-2.0 | ≈-2.0 | · | · | |
| Price / Cash Flow (TTM) | -0.95Y avg ≈-2.0 | ≈-2.0 | · | · | |
| Price / Tangible Book | 0.65Y avg ≈15.1 | ≈15.1 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PHIO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -63.9%5Y avg ≈-79.2% | ≈-79.2% | -94.8% | Top tier | |
| ROE | -57.5%5Y avg ≈-111.1% | ≈-111.1% | -165.1% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.17%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.36 | $-0.37 | 2.0% |
| March 31, 2026 | May 13, 2026 | $-0.34 | $-0.24 | -41.8% |
| Dec. 31, 2025 | $-0.25 | $-0.35 | 27.0% | |
| Sept. 30, 2025 | $-0.44 | $-0.46 | 4.1% | |
| June 30, 2025 | $-0.45 | $-0.37 | -22.5% | |
| Dec. 31, 2024 | $-0.85 | $-1.25 | 32.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $0 | $21.0K | $138.0K | $15.0K | $19.0K | $34.0K | · | |
| R&D Expense | $5M | $4M | $6M | $7M | $9M | $4M | $4M | $4M | $5M | $5M | $7M | $6M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $9M | $7M | $11M | $11M | $14M | $9M | $9M | $8M | $14M | $9M | $10M | $9M | |
| Operating Income | $-9M | $-7M | $-11M | $-11M | $-14M | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M | |
| Other Non-op | $2.0K | $6.0K | $-2.0K | $-18.0K | $224.0K | $-1.0K | $79.0K | $4.0K | $-11.0K | $6.0K | $-2.0K | $9.0K | |
| Pretax Income | · | · | · | $-11M | $-13M | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-2M | $0 | $0 | $0 | |
| Net Income | $-9M | $-7M | $-11M | $-11M | $-13M | $-9M | $-9M | $-7M | $-12M | $-9M | $-10M | $-9M | |
| EPS (Basic) | $-1.45 | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · | |
| Shares (Basic) | 5,984,017 | 787,466 | 231,508 | 1,136,566 | 1,069,234 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | 787,466 | 231,508 | 1,136,566 | 1,069,234 | · | · | · | · | · | · | · | |
| EBITDA | $-9M | $-7M | $-11M | $-11M | · | $-9M | $-9M | $-7M | $-14M | $-9M | $-10M | $-9M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $5M | $8M | $12M | $24M | $14M | $7M | $15M | $4M | $13M | $5M | $8M | |
| Prepaid Expense | $445.0K | $354.0K | $832.0K | $615.0K | $620.0K | $870.0K | $316.0K | $221.0K | $201.0K | $150.0K | $311.0K | $442.0K | |
| Current Assets | $21M | $6M | $9M | $12M | $25M | $15M | $7M | $15M | $4M | $13M | $11M | $9M | |
| PP&E (Net) | $11.0K | $2.0K | $6.0K | $183.0K | $133.0K | $157.0K | $210.0K | $172.0K | $248.0K | $114.0K | $163.0K | $183.0K | |
| PP&E (Gross) | $239.0K | $308.0K | $1M | $1M | $1M | · | · | · | · | · | · | · | |
| Accum. Depreciation | $228.0K | $306.0K | $1M | $1M | $1M | $1M | $1M | $981.0K | $900.0K | $831.0K | $778.0K | $702.0K | |
| Other Non-current Assets | · | $0 | $3.0K | $24.0K | $27.0K | $18.0K | $18.0K | $0 | $18.0K | $27.0K | $18.0K | $18.0K | |
| Total Assets | $21M | $6M | $9M | $13M | $25M | $16M | $8M | $15M | $4M | $13M | $11M | $9M | |
| Accounts Payable | $435.0K | $253.0K | $657.0K | $779.0K | $283.0K | $728.0K | $809.0K | $550.0K | $511.0K | $917.0K | $1M | $285.0K | |
| Accrued Liabilities | $905.0K | $762.0K | $942.0K | $1M | $3M | $1M | $964.0K | $1M | $2M | $2M | $1M | $1M | |
| Current Liabilities | · | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Capital Leases | · | $0 | $0 | $35.0K | $170.0K | $295.0K | $411.0K | $0 | · | · | · | · | |
| Total Liabilities | $1M | $1M | $2M | $2M | $3M | $3M | $2M | $2M | · | · | · | · | |
| Total Debt | · | · | · | · | · | $231.0K | · | · | · | · | · | · | |
| Common Stock | $1.0K | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $0 | $0 | $0 | $1.0K | $2.0K | |
| Paid-in Capital | $175M | $151M | $147M | $139M | $139M | $117M | $101M | $99M | $80M | $73M | $66M | $48M | |
| Retained Earnings | $-155M | $-146M | $-139M | $-128M | $-117M | $-104M | $-95M | $-86M | $-79M | $-66M | $-57M | $-47M | |
| Stockholders' Equity | $20M | $5M | $8M | $11M | $22M | $13M | $6M | $14M | $2M | $11M | $9M | $3M | |
| Liabilities + Equity | $21M | $6M | $9M | $13M | $25M | $16M | $8M | $15M | $4M | $13M | $11M | $9M | |
| Shares Outstanding | 11,617,250 | 1,733,717 | 416,368 | 1,139,024 | 1,127,917 | 5,780,973 | 669,433 | 342,578 | 2,429,993 | 1,300,318 | 653,485 | 21,984,272 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $2.0K | $56.0K | $71.0K | $75.0K | $72.0K | $67.0K | $81.0K | $70.0K | $53.0K | $77.0K | $87.0K | |
| Stock-based Comp | $481.0K | $147.0K | $303.0K | $414.0K | $480.0K | $136.0K | $300.0K | $282.0K | $314.0K | $756.0K | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | $-2M | $-4M | $-4M | $-3M | |
| Other Non-cash | $235.0K | $-111.0K | $-282.0K | $-1M | · | $-216.0K | $-104.0K | $-523.0K | $4M | $4M | $5M | $2M | |
| Operating Cash Flow | $-8M | $-7M | $-11M | $-12M | $-12M | $-9M | $-9M | $-8M | $-10M | $-8M | $-7M | $-8M | |
| CapEx | $12.0K | $1.0K | $5.0K | $121.0K | $51.0K | $19.0K | $72.0K | $5.0K | $203.0K | $4.0K | $57.0K | $95.0K | |
| Investing Cash Flow | $-12.0K | $8.0K | $-5.0K | $-121.0K | $-51.0K | $-19.0K | $-72.0K | $-5.0K | $-103.0K | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $1M | $290.0K | · | $9M | $2M | |
| Net Stock Activity | · | · | · | · | · | · | · | $1M | · | · | $9M | $2M | |
| Financing Cash Flow | $24M | $4M | $7M | $-26.0K | $22M | $16M | $772.0K | $19M | $292.0K | · | · | · | |
| Net Change in Cash | $16M | $-3M | · | · | · | · | · | $11M | $-9M | $8M | $-3M | $-3M | |
| Free Cash Flow | $-8M | $-7M | $-11M | $-12M | · | $-9M | $-9M | $-8M | $-10M | $-8M | $-7M | $-8M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -3197.8% | · | · | · | · | -42795.2% | -5336.2% | -93746.7% | -47447.4% | · | · | |
| Net Margin | · | -3095.2% | · | · | · | · | -42419.0% | -5333.3% | -83013.3% | -47336.8% | · | · | |
| Pretax Margin | · | · | · | · | · | · | -42419.0% | -5333.3% | -93820.0% | -47336.8% | · | · | |
| EBITDA Margin | · | -3197.0% | · | · | · | · | -42476.2% | -5277.5% | -93280.0% | -47168.4% | · | · | |
| ROA | -63.9% | -94.7% | -97.6% | -60.5% | · | -74.0% | -76.3% | -75.8% | -142.3% | -73.2% | -100.5% | -73.0% | |
| ROE | -57.5% | -147.9% | -144.9% | -94.2% | · | -61.8% | -133.4% | -96.0% | -196.3% | -91.1% | -175.7% | -229.0% | |
| ROIC | · | · | · | -105.8% | · | -66.4% | -156.3% | -54.2% | -678.8% | -83.0% | -115.1% | -321.5% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.7 | 5.7 | 6.4 | · | 6.9 | 3.9 | 8.7 | 1.7 | 5.2 | 4.8 | 6.7 | |
| Quick Ratio | · | 5.3 | 5.2 | 6.1 | · | 6.5 | 3.7 | 8.5 | 1.6 | 5.1 | 2.3 | 6.4 | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.73 | $2.72 | $2.06 | $9.52 | · | $2.25 | $8.59 | $0.72 | $1.41 | $0.83 | $0.14 | $0.23 | |
| Revenue / Share | · | $0.29 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-9.03 | $-5.16 | $-10.67 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.81 | $3.10 | $2.27 | $10.34 | · | $2.46 | $10.36 | $0.79 | $2.75 | $0.99 | $0.08 | $0.72 | |
| EPS (TTM) | $-6.02 | $-9.08 | $-46.76 | $-10.10 | $-12.43 | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $21.0K | $138.0K | $15.0K | $19.0K | $34.0K | $399.0K | |
| Net Income TTM | $-9M | $-7M | $-11M | $-11M | $-13M | $-9M | $-9M | $-7M | $-12M | $-9M | $-10M | $-9M | |
| Market Cap | $12M | $3M | $26M | $46M | · | $1.68B | $680M | $36.93B | $42.94B | $552.26B | $14.83T | $11.20T | |
| Enterprise Value | · | · | · | · | · | $1.67B | · | · | · | · | · | · | |
| P/E | -0.2 | -0.2 | -0.1 | -4.0 | -8.7 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | 32379.5 | 267635.7 | 2862988.0 | 29066211.3 | 436124657.3 | 28078591.4 | |
| P/B | 0.6 | 0.7 | 3.3 | 4.2 | · | 129.0 | 118.3 | 2720.1 | 23428.7 | 50875.9 | 1667968.3 | 4081369.0 | |
| P / Tangible Book | 0.6 | 0.7 | 3.3 | 4.2 | 66.7 | 129.0 | · | · | · | · | · | · | |
| P / Cash Flow | -1.5 | -0.4 | -2.4 | -3.8 | · | -190.8 | -78.7 | -4911.4 | -4513.9 | -71167.3 | -2026546.2 | -1444103.9 | |
| P / FCF | -1.5 | -0.4 | -2.4 | -3.7 | · | -190.4 | -78.0 | -4908.1 | -4419.6 | -71130.6 | -2010881.3 | -1426634.1 | |
| EV / EBITDA | · | · | · | · | · | -191.0 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -188.8 | · | · | · | · | · | · | |
| Earnings Yield | -573.3% | -504.4% | -683.6% | -25.1% | -11.5% | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $3M | $1M | $1M | $1M | $886.0K | $985.0K | $644.0K | $866.0K | $1M | $1M | $2M | $1M | $2M | $2M | $3M | |
| SG&A Expense | $1M | $1M | $1M | $1M | $1M | $986.0K | $689.0K | $946.0K | $1M | $1M | $766.0K | $968.0K | $1M | $1M | $1M | $1M | |
| Operating Expenses | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | |
| Operating Income | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-4M | |
| Other Non-op | $0 | $3.0K | $-119.0K | $0 | $0 | $-22.0K | $-64.0K | $0 | $68.0K | $2.0K | · | $-4.0K | $-2.0K | $0 | $-1.0K | $-5.0K | |
| Net Income | $-4M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-4M | $-3M | $-4M | |
| EPS (Basic) | $-0.36 | $-0.34 | $-0.15 | $-0.44 | $-0.45 | $-0.41 | $-3.45 | $-1.54 | $-3.62 | $-0.47 | $-20.09 | $-10.25 | $-13.27 | $-3.15 | $-2.40 | $-3.14 | |
| EPS (Diluted) | · | · | · | · | $-0.45 | $-0.41 | · | $-1.54 | $-3.62 | $-0.47 | $-20.09 | $-10.25 | $-13.27 | $-3.15 | $-2.40 | $-3.14 | |
| Shares (Basic) | 11,617,250 | 11,617,250 | · | 5,468,584 | 4,794,857 | 4,307,264 | · | 990,033 | 510,188 | 4,580,072 | · | 271,129 | 192,054 | 1,142,213 | · | 1,138,571 | |
| Shares (Diluted) | · | · | · | · | 4,794,857 | 4,307,264 | · | 990,033 | 510,188 | 4,580,072 | · | 271,129 | 192,054 | 1,142,213 | · | 1,138,571 | |
| EBITDA | $-4M | $-4M | · | $-3M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-4M | · | $-4M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $21M | $11M | $11M | $13M | $5M | $5M | $5M | $6M | $8M | $8M | $11M | $9M | $12M | $14M | |
| Prepaid Expense | $1M | $371.0K | $445.0K | $788.0K | $519.0K | $158.0K | $354.0K | $474.0K | $594.0K | $373.0K | $832.0K | $871.0K | $678.0K | $319.0K | $615.0K | $843.0K | |
| Current Assets | $14M | $17M | $21M | $11M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $9M | $12M | $9M | $12M | $15M | |
| PP&E (Net) | $9.0K | $10.0K | $11.0K | $12.0K | $7.0K | $4.0K | $2.0K | $1.0K | $1.0K | $2.0K | $6.0K | $142.0K | $157.0K | $167.0K | $183.0K | $198.0K | |
| PP&E (Gross) | · | · | $239.0K | · | · | · | $308.0K | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $228.0K | · | · | · | $306.0K | · | · | · | $1M | · | · | · | $1M | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | $3.0K | $3.0K | $6.0K | $6.0K | $24.0K | $24.0K | |
| Total Assets | $14M | $17M | $21M | $12M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $10M | $12M | $10M | $13M | $16M | |
| Accounts Payable | $901.0K | $260.0K | $435.0K | $516.0K | $235.0K | $427.0K | $253.0K | $184.0K | $335.0K | $320.0K | $657.0K | $173.0K | $641.0K | $902.0K | $779.0K | $543.0K | |
| Accrued Liabilities | $804.0K | $690.0K | $905.0K | $1M | $971.0K | $843.0K | $762.0K | $735.0K | $1M | $929.0K | $942.0K | $2M | $2M | $1M | $1M | $2M | |
| Current Liabilities | · | · | · | · | $1M | $1M | · | $919.0K | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $35.0K | $70.0K | |
| Total Liabilities | $2M | $950.0K | $1M | $2M | $1M | $1M | $1M | · | · | · | $2M | $2M | $2M | $2M | $2M | $2M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | |
| Paid-in Capital | $176M | $176M | $175M | $163M | $160M | $160M | $151M | $150M | $147M | $147M | $147M | $145M | $144M | $139M | $139M | $139M | |
| Retained Earnings | $-163M | $-159M | $-155M | $-153M | $-150M | $-148M | $-146M | $-145M | $-143M | $-141M | $-139M | $-137M | $-135M | $-132M | $-128M | $-126M | |
| Stockholders' Equity | $13M | $16M | $20M | $10M | $10M | $12M | $5M | $5M | $4M | $6M | $8M | $7M | $10M | $7M | $11M | $14M | |
| Liabilities + Equity | $14M | $17M | $21M | $12M | $11M | $13M | $6M | $6M | $5M | $7M | $9M | $10M | $12M | $10M | $13M | $16M | |
| Shares Outstanding | 11,617,250 | 11,617,250 | 11,617,250 | 5,784,770 | 4,798,154 | 4,778,154 | 1,733,717 | 958,219 | 510,188 | 4,591,700 | 416,368 | 2,307,385 | 1,985,211 | 1,150,582 | 1,139,024 | 13,667,973 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $10.0K | $15.0K | $15.0K | $16.0K | $15.0K | $15.0K | |
| Stock-based Comp | $278.0K | $318.0K | $274.0K | $113.0K | $51.0K | $43.0K | $48.0K | $52.0K | $15.0K | $32.0K | $9.0K | $89.0K | $94.0K | $111.0K | $42.0K | $103.0K | |
| Other Non-cash | · | $-319.0K | · | · | · | $451.0K | · | · | · | $110.0K | · | · | · | $767.0K | · | · | |
| Operating Cash Flow | $-4M | $-4M | $-2M | $-2M | $-3M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-4M | |
| CapEx | $0 | $0 | $0 | $7.0K | $3.0K | $2.0K | $1.0K | $0 | $0 | $0 | $0 | $0 | $5.0K | $0 | $0 | $7.0K | |
| Investing Cash Flow | $0 | $3.0K | $0 | $-7.0K | $-3.0K | $-2.0K | $8.0K | $0 | $0 | $0 | $0 | $0 | $-5.0K | $0 | $0 | $-7.0K | |
| Financing Cash Flow | $0 | $0 | $12M | $2M | $40.0K | $9M | $1M | $3M | $0 | $-4.0K | $2M | $0 | $5M | $-38.0K | $2.0K | $-3.0K | |
| Net Change in Cash | $-4M | $-4M | $10M | $-70.0K | $-3M | $8M | $-8.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-4M | · | · | · | $-1M | · | · | · | · | · | · | · | $-3M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -32.3% | -25.9% | · | -27.5% | -26.1% | -17.4% | · | -19.8% | -21.0% | -26.0% | · | -21.9% | -15.7% | -22.6% | · | -16.4% | |
| ROE | -36.5% | -28.0% | · | -32.4% | -31.2% | -19.9% | · | -25.1% | -27.0% | -33.4% | · | -26.8% | -18.9% | -26.9% | · | -18.4% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 9.4 | 10.6 | · | 6.4 | 3.5 | 5.5 | · | 4.0 | 5.0 | 3.9 | · | 7.0 | |
| Quick Ratio | · | · | · | · | 8.9 | 10.5 | · | 5.9 | 3.1 | 5.2 | · | 3.6 | 4.7 | 3.8 | · | 6.6 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.08 | $1.42 | · | $1.70 | $2.10 | $2.55 | · | $5.16 | $7.40 | $1.22 | · | $3.13 | $4.99 | $6.35 | · | $0.99 | |
| Cash Flow / Share | · | · | · | · | · | $-0.30 | · | · | · | $-0.44 | · | · | · | $-2.37 | · | · | |
| Cash / Share | $1.12 | $1.47 | · | $1.85 | $2.25 | $2.78 | · | $5.62 | $9.21 | $1.41 | · | $3.64 | $5.70 | $7.85 | · | $1.06 | |
| EPS (TTM) | · | · | · | · | · | · | · | $-25.72 | $-34.43 | $-44.08 | · | $-29.07 | $-21.96 | $-10.91 | · | $-19.33 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-13M | $-11M | · | $-8M | $-7M | $-7M | · | $-7M | $-9M | $-9M | · | $-12M | $-12M | $-12M | · | $-12M | |
| Market Cap | $12M | $14M | · | $14M | $11M | $6M | · | $3M | $3M | $28M | · | $31M | $51M | $58M | · | $843M | |
| P/E | · | · | · | · | · | · | · | -0.1 | -0.2 | -0.1 | · | -0.5 | -1.2 | -4.6 | · | -3.2 | |
| P/B | 0.9 | 0.9 | · | 1.5 | 1.1 | 0.5 | · | 0.7 | 0.8 | 5.0 | · | 4.3 | 5.2 | 8.0 | · | 62.3 | |
| P / Tangible Book | 0.9 | 0.9 | · | 1.5 | 1.1 | 0.5 | · | 0.7 | 0.8 | 5.0 | · | 4.3 | 5.2 | 8.0 | · | 62.3 | |
| P / Cash Flow | · | -3.5 | · | · | · | -4.9 | · | · | · | -14.0 | · | · | · | -21.5 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | -745.5% | -552.8% | -720.3% | · | -213.9% | -85.0% | -21.6% | · | -31.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Margin % | · | -3197.8% | · | · | · |
| Net Income | $-9M | $-7M | $-11M | $-11M | $-13M |
| Diluted EPS | · | $-9.08 | $-46.76 | $-10.10 | $-12.43 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | · | 5.7 | 5.7 | 6.4 | · |
| Quick Ratio | · | 5.3 | 5.2 | 6.1 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-8M | $-7M | $-11M | $-12M | · |
Institutional owners (13F) 25 filers · $742K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
25
Value held
$742K
New positions
4
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (-11 vs prior Q) | 4 (-1 vs prior Q) | 6 (+1 vs prior Q) | 8 (+8 vs prior Q) | -21K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $120,699 | 117,755 | 16.28% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $117,437 | 114,574 | 15.84% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $96,619 | 94,262 | 13.03% | Shares |
| VANGUARD GROUP INC | $92,009 | 87,628 | 12.41% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $51,000 | 50,000 | 6.88% | Shares |
| Cetera Investment Advisers | $48,688 | 47,500 | 6.57% | Shares |
| CITADEL ADVISORS LLC | $48,329 | 47,150 | 6.52% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $39,123 | 38,169 | 5.28% | Shares |
| NORTHERN TRUST CORP | $28,462 | 27,768 | 3.84% | Shares |
| TWO SIGMA INVESTMENTS, LP | $22,039 | 21,501 | 2.97% | Shares |
| XTX Topco Ltd | $18,937 | 18,475 | 2.55% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $12,300 | 12,000 | 1.66% | Shares |
| CITIGROUP INC | $11,895 | 11,605 | 1.60% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $10,250 | 10,000 | 1.38% | Shares |
| Tower Research Capital LLC (TRC) | $6,361 | 6,206 | 0.86% | Shares |
| MORGAN STANLEY | $6,150 | 6,000 | 0.83% | Shares |
| UBS Group AG | $5,522 | 5,387 | 0.74% | Shares |
| OSAIC HOLDINGS, INC. | $2,060 | 2,000 | 0.28% | Shares |
| Spire Wealth Management | $2,050 | 1,990 | 0.28% | Shares |
| SBI Securities Co., Ltd. | $1,278 | 1,247 | 0.17% | Shares |
| BARCLAYS PLC | $237 | 231 | 0.03% | Shares |
| ASSETMARK, INC | $113 | 110 | 0.02% | Shares |
| HRT FINANCIAL LP | $13 | 13,182 | 0.00% | Shares |
| Activest Wealth Management | $9 | 9 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $6 | 6 | 0.00% | Shares |
Company insiders 19 insiders · 8 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert J Bitterman | Chairman, Pres. & CEO | Sept. 28, 2026 A | 764,871 | 7 | 0 | $44,860 |
| Gerrit Dispersyn | President & CEO | March 1, 2022 F | 212,327 | 0 | 0 | $0 |
| Lisa Cabott Carson | Chief Financial Officer | Sept. 28, 2026 A | 189,112 | 0 | 0 | $0 |
| Robert M. Infarinato | VP, CFO | Sept. 11, 2024 A | 11,000 | 0 | 0 | $0 |
| Caitlin Kontulis | Secretary & VP Finance & Admin | March 1, 2024 F | 10,643 | 0 | 0 | $0 |
| John A Barrett | Chief Development Officer | April 22, 2019 A | 222,991 | 0 | 0 | $0 |
| Alexey Eliseev | Chief Business Officer | Sept. 7, 2017 S | 950,312 | 0 | 0 | $0 |
| Pamela Pavco | Chief Development Officer | Feb. 1, 2017 A | 17,173 | 0 | 0 | $0 |
| Ronald Todd Plott | Director | Sept. 29, 2026 P | 42,000 | 3 | 0 | $27,450 |
| Patricia A Bradford | Director | Sept. 24, 2026 P | 64,151 | 2 | 0 | $18,925 |
| Jonathan E Freeman | Director | Feb. 5, 2026 A | 32,655 | 0 | 0 | $0 |
| David H Deming | Director | Feb. 5, 2026 A | 37,800 | 0 | 0 | $0 |
| Curtis Lockshin | Director | Feb. 5, 2026 A | 35,155 | 0 | 0 | $0 |
| Robert L Ferrara | Director | Sept. 11, 2025 A | 38,766 | 0 | 0 | $0 |
| Geert Cauwenbergh | Director | Feb. 17, 2023 A | 4,235 | 0 | 0 | $0 |
| Paul H. Dorman | Director | Feb. 15, 2022 A | 20,370 | 0 | 0 | $0 |
| Keith L Brownlie | Director | Feb. 13, 2019 A | 20,000 | 0 | 0 | $0 |
| Advanced RNA Technologies, LLC | · | July 31, 2014 P | 1,221,723 | 0 | 0 | $0 |
| Galena Biopharma, Inc. | · | May 2, 2013 S | 32,393,095 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 94,262 SH | Aug. 19, 2026 | Daily |
PHIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$14.00
+1321.2%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-30Mean target $14.00 +1321.2%
Low$14.00
Mean$14.00
High$14.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026